Prospective Prostate Cancer and Patient-reported Outcomes Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

standard of care: No other procedures than those performed during the usual care for prostate cancer patients will be done. No study medication will be provided as part of participation. Clinical outcomes will be reported via predefined electronic forms, integrated into the electronic health record (EHR). Patient-reported outcomes will be collected electronically. All treatment decisions will be made at the discretion of the investigator or treating physician.

Study summary

This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.

Eligibility

Primary outcome measure(s)

• Assessment of systematically reporting a standardized set of predefined clinical parameters — up to 10 years after diagnosis
  The proportion of patients who are enrolled in the registry over the total localized and locally advanced prostate cancer patients
• Assessment of systematically collecting a predefined set of patient-reported outcomes — up to 10 years after diagnosis
  The proportion of patients who completed all questionnaires over the total of questionnaires send.

Trial sites (4)

More Universitaire Ziekenhuizen KU Leuven trials in Belgium

Other trials for the same condition